207 related articles for article (PubMed ID: 11689575)
1. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
Sliva D; Rizzo MT; English D
J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
4. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation.
Reddy SA; Huang JH; Liao WS
J Immunol; 2000 Feb; 164(3):1355-63. PubMed ID: 10640750
[TBL] [Abstract][Full Text] [Related]
8. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit.
Sizemore N; Leung S; Stark GR
Mol Cell Biol; 1999 Jul; 19(7):4798-805. PubMed ID: 10373529
[TBL] [Abstract][Full Text] [Related]
9. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction.
Kusch A; Tkachuk S; Haller H; Dietz R; Gulba DC; Lipp M; Dumler I
J Biol Chem; 2000 Dec; 275(50):39466-73. PubMed ID: 10995743
[TBL] [Abstract][Full Text] [Related]
10. Requirement of phosphatidylinositol 3-kinase activity for bradykinin stimulation of NF-kappaB activation in cultured human epithelial cells.
Pan ZK; Christiansen SC; Ptasznik A; Zuraw BL
J Biol Chem; 1999 Apr; 274(15):9918-22. PubMed ID: 10187765
[TBL] [Abstract][Full Text] [Related]
11. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
Bone H; Williams NA
Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
[TBL] [Abstract][Full Text] [Related]
12. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.
Sliva D; Labarrere C; Slivova V; Sedlak M; Lloyd FP; Ho NW
Biochem Biophys Res Commun; 2002 Nov; 298(4):603-12. PubMed ID: 12408995
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB.
Heck S; Lezoualc'h F; Engert S; Behl C
J Biol Chem; 1999 Apr; 274(14):9828-35. PubMed ID: 10092673
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells.
Pahan K; Raymond JR; Singh I
J Biol Chem; 1999 Mar; 274(11):7528-36. PubMed ID: 10066820
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of transactivation function but not DNA binding of NF-kappaB and AP-1 by IkappaBbeta1 in breast cancer cells.
Newton TR; Patel NM; Bhat-Nakshatri P; Stauss CR; Goulet RJ; Nakshatri H
J Biol Chem; 1999 Jun; 274(26):18827-35. PubMed ID: 10373501
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
Shin S; Kim MK; Jung W; Chong Y
Phytother Res; 2018 Oct; 32(10):2086-2096. PubMed ID: 30009577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
